15.46

1.09% -0.22

Aurinia Pharmaceuticals Inc (AUPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AUPH? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$15.68

Offen:

$15.6

24-Stunden-Volumen:

687.45K

Relative Volume:

0.42

Marktkapitalisierung:

$2.03B

Einnahmen:

$260.11M

Nettoeinkommen (Verlust:

$60.64M

KGV:

35.95

EPS:

0.43

Netto-Cashflow:

$92.29M

1W Leistung:

-2.52%

1M Leistung:

+6.16%

6M Leistung:

+90.53%

1J Leistung:

+69.87%

1-Tages-Spanne:

$15.41

$15.82

1-Wochen-Bereich:

$14.70

$16.03

52-Wochen-Spanne:

$6.55

$16.48

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Firmenname

Aurinia Pharmaceuticals Inc

Sektor

Healthcare (1139)

Branche

Biotechnology (634)

Telefon

250-744-2487

Adresse

#140, 14315 - 118 AVENUE, EDMONTON, BC

Mitarbeiter

300

Twitter

@AuriniaPharma

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

AUPH's Discussions on Twitter

Vergleichen Sie AUPH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AUPH Aurinia Pharmaceuticals Inc	15.44	2.07B	260.11M	60.64M	92.29M	0.43
VRTX Vertex Pharmaceuticals Inc	438.54	112.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	700.32	73.91B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	417.88	56.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	892.74	55.46B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	193.73	41.92B	447.02M	-1.18B	-906.14M	-6.1812

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-03	Herabstufung	Leerink Partners	Outperform → Market Perform
2025-11-07	Hochstufung	Jefferies	Hold → Buy
2025-11-05	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2025-07-30	Fortgesetzt	H.C. Wainwright	Buy
2022-11-04	Herabstufung	Oppenheimer	Outperform → Perform
2022-05-05	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-12-10	Hochstufung	Oppenheimer	Perform → Outperform
2021-10-28	Herabstufung	Oppenheimer	Outperform → Perform
2021-01-25	Bestätigt	H.C. Wainwright	Buy
2020-11-03	Bestätigt	H.C. Wainwright	Buy
2020-06-17	Eingeleitet	BTIG Research	Buy
2020-05-05	Eingeleitet	Cowen	Outperform
2020-01-10	Eingeleitet	Jefferies	Buy
2019-12-16	Bestätigt	H.C. Wainwright	Buy
2018-03-16	Bestätigt	Cantor Fitzgerald	Overweight
2018-02-08	Eingeleitet	RBC Capital Mkts	Outperform
2017-10-30	Bestätigt	H.C. Wainwright	Buy
2017-05-18	Bestätigt	H.C. Wainwright	Buy
2017-04-11	Eingeleitet	Cantor Fitzgerald	Overweight
2017-03-22	Bestätigt	FBR & Co.	Outperform
2016-12-30	Bestätigt	H.C. Wainwright	Buy
2016-08-17	Bestätigt	H.C. Wainwright	Buy
2016-06-30	Eingeleitet	H.C. Wainwright	Buy
2015-05-08	Eingeleitet	MLV & Co	Buy

Alle ansehen

Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten

Dec 07, 2025

Earnings Report: Can Aurinia Pharmaceuticals Inc stock deliver 10 annual returns2025 AllTime Highs & Long-Term Safe Investment Ideas - BỘ NỘI VỤ

Dec 07, 2025

State Board of Administration of Florida Retirement System Has $1.22 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Dec 07, 2025

Dec 06, 2025

Schroder Investment Management Group Has $4.64 Million Holdings in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Dec 06, 2025

Dec 05, 2025

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - sharewise.com

Dec 05, 2025

Will Aurinia Pharmaceuticals Inc. (IKAP) stock return to pre crash levelsWeekly Trade Report & Low Risk Entry Point Guides - Newser

Dec 05, 2025

Can Aurinia Pharmaceuticals Inc. stock weather global recessionWeekly Trade Review & Detailed Earnings Play Alerts - Newser

Dec 05, 2025

Dec 04, 2025

How Aurinia Pharmaceuticals Inc. (IKAP) stock valuation compares with sectorJuly 2025 Action & High Accuracy Trade Signal Alerts - Newser

Dec 04, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 5.2%Time to Sell? - MarketBeat

Dec 04, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Hold Rating by Leerink Partnrs - MarketBeat

Dec 04, 2025

Can Aurinia Pharmaceuticals Inc. stock surprise with earnings upsideStock Surge & Reliable Price Breakout Signals - Newser

Dec 04, 2025

Dec 03, 2025

Aurinia Pharmaceuticals Shares Fall After Leerink Partners Downgrade - marketscreener.com

Dec 03, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years - 富途牛牛

Dec 03, 2025

Leerink Partners downgrades Aurinia Pharmaceuticals stock rating on growth concerns - Investing.com Canada

Dec 03, 2025

Leerink Partners Downgrades Aurinia Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $16 From $15 - marketscreener.com

Dec 03, 2025

Will Aurinia Pharmaceuticals Inc. stock sustain high P E ratios2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser

Dec 03, 2025

Dec 02, 2025

Defamation Litigation Roundup: FDA, Lively, Alexander Bros. - Law360

Dec 02, 2025

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - Yahoo Finance

Dec 02, 2025

Trading Systems Reacting to (AUPH) Volatility - news.stocktradersdaily.com

Dec 02, 2025

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - sharewise.com

Dec 02, 2025

Will Aurinia Pharmaceuticals Inc. (IKAP) stock test record highs in 2025Analyst Downgrade & Weekly Setup with ROI Potential - Newser

Dec 02, 2025